FucosterolCAS# 17605-67-3 |
2D Structure
- Delta 5-avenasterol
Catalog No.:BCN3211
CAS No.:18472-36-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 17605-67-3 | SDF | Download SDF |
PubChem ID | 5281328 | Appearance | Powder |
Formula | C29H48O | M.Wt | 412.69 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Synonyms | trans-24-Ethylidencholesterol; Stigmasta 5,24(28)-diene 3β-ol | ||
Solubility | Soluble in methanol; insoluble in water | ||
Chemical Name | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(E,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | ||
SMILES | CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | ||
Standard InChIKey | OSELKOCHBMDKEJ-JUGJNGJRSA-N | ||
Standard InChI | InChI=1S/C29H48O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h7,10,19-20,23-27,30H,8-9,11-18H2,1-6H3/b21-7+/t20-,23+,24+,25-,26+,27+,28+,29-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Fucosterol has anti-diabetic activity in vivo, it exhibits an inhibition of sorbitol accumulations in the lenses and causes an inhibition of blood glucose level and glycogen degradation. 2. Fucosterol possesses anti-oxidant and hepatoprotective activities . 3. Fucosterol shows cytotoxic effect against breast and colon carcinoma cell lines. 4. Fucosterol exhibits anti-inflammatory activity which might attribute to inhibition of NO and ROS generation and suppression of the NF-κB pathway. 5. Fucosterol is a dual-LXR agonist that regulates the expression of key genes in cholesterol homeostasis in multiple cell lines without inducing hepatic triglyceride accumulation. 6. Fucosterol has antihistaminic, anticholinergic and antiviral activities. 7. Fucosterol could as an anti-obesity agent, it can inhibit expression of PPARγ and C/EBPα, resulting in a decrease of lipid accumulation in 3T3-L1 pre-adipocytes. |
Targets | SOD | NO | ROS | NOS | COX | NF-kB | Liver X Receptor | PPAR |
Fucosterol Dilution Calculator
Fucosterol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4231 mL | 12.1156 mL | 24.2313 mL | 48.4625 mL | 60.5782 mL |
5 mM | 0.4846 mL | 2.4231 mL | 4.8463 mL | 9.6925 mL | 12.1156 mL |
10 mM | 0.2423 mL | 1.2116 mL | 2.4231 mL | 4.8463 mL | 6.0578 mL |
50 mM | 0.0485 mL | 0.2423 mL | 0.4846 mL | 0.9693 mL | 1.2116 mL |
100 mM | 0.0242 mL | 0.1212 mL | 0.2423 mL | 0.4846 mL | 0.6058 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (±)-Sigmoidin A
Catalog No.:BCN3372
CAS No.:176046-04-1
- Valganciclovir HCl
Catalog No.:BCC4745
CAS No.:175865-59-5
- Wedelialactone A
Catalog No.:BCN6733
CAS No.:175862-40-5
- H-Dab.HBr
Catalog No.:BCC3184
CAS No.:1758-80-1
- PPAHV
Catalog No.:BCC7077
CAS No.:175796-50-6
- Lanatoside C
Catalog No.:BCN6457
CAS No.:17575-22-3
- Lanatoside B
Catalog No.:BCN6544
CAS No.:17575-21-2
- α-Conotoxin MII
Catalog No.:BCC5743
CAS No.:175735-93-0
- Tapentadol Hydrochloride
Catalog No.:BCC9159
CAS No.:175591-09-0
- Longifloroside A
Catalog No.:BCN1123
CAS No.:175556-08-8
- Voreloxin Hydrochloride
Catalog No.:BCC2045
CAS No.:175519-16-1
- Fmoc-Phe(4-Cl)-OH
Catalog No.:BCC3173
CAS No.:175453-08-4
- Zerumin A
Catalog No.:BCN3684
CAS No.:176050-48-9
- H-Val-OEt.HCl
Catalog No.:BCC3141
CAS No.:17609-47-1
- Maribavir
Catalog No.:BCC5259
CAS No.:176161-24-3
- Depressine
Catalog No.:BCN7851
CAS No.:176182-06-2
- LY 354740
Catalog No.:BCC7614
CAS No.:176199-48-7
- Nervogenic acid
Catalog No.:BCN1124
CAS No.:17622-86-5
- D-Raffinose Pentahydrate
Catalog No.:BCN2567
CAS No.:17629-30-0
- Dihydropinosylvin methyl ether
Catalog No.:BCN1125
CAS No.:17635-59-5
- Fmoc-D-Thr-ol
Catalog No.:BCC2575
CAS No.:176380-53-3
- 16alpha-Hydroxydehydrotrametenolic acid
Catalog No.:BCN1523
CAS No.:176390-66-2
- 16 alpha-Hydroxytrametenolic acid
Catalog No.:BCN2917
CAS No.:176390-68-4
- Nicotiflorin
Catalog No.:BCN1126
CAS No.:17650-84-9
Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages.[Pubmed:23774261]
Food Chem Toxicol. 2013 Sep;59:199-206.
Although individual phlorotannins contained in the edible brown algae have been reported to possess strong anti-inflammatory activity, the responsible components of Eisenia bicyclis have yet to be fully studied. Thus, we evaluated their anti-inflammatory activity via inhibition against production of lipopolysaccharide (LPS)-induced nitric oxide (NO) and tert-butylhydroperoxide (t-BHP)-induced reactive oxygen species (ROS), along with suppression against expression of inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2), in RAW 264.7 cells. The anti-inflammatory activity potential of the methanolic extract and its fractions of E. bicyclis was in the order of dichloromethane>methanol>ethyl acetate>n-butanol. The strong anti-inflammatory dichloromethane fraction was further purified to yield Fucosterol. From the ethyl acetate fraction, six known phlorotannins were isolated: phloroglucinol, eckol, dieckol, 7-phloroeckol, phlorofucofuroeckol A and dioxinodehydroeckol. We found that these compounds, at non-toxic concentrations, dose-dependently inhibited LPS-induced NO production. Fucosterol also inhibited t-BHP-induced ROS generation and suppressed the expression of iNOS and COX-2. These results indicate that E. bicyclis and its constituents exhibited anti-inflammatory activity which might attribute to inhibition of NO and ROS generation and suppression of the NF-kappaB pathway and can therefore be considered as a useful therapeutic and preventive approach to various inflammatory and oxidative stress-related diseases.
Cytotoxicity of fucosterol containing fraction of marine algae against breast and colon carcinoma cell line.[Pubmed:22438665]
Pharmacogn Mag. 2012 Jan;8(29):60-4.
CONTEXT: Marine algae produce different secondary metabolites with a wide range of biological activities. Many studies have been achieved on the screening of biological effects of marine organisms and a lot of active compounds were isolated and characterized. AIMS: In an attempt to find cytotoxic compound of hexane fraction, isolation, identification, and cytotoxicity of active compound of this fraction were performed. MATERIALS AND METHODS: In this study, total methanolic (70%) extract and partition fractions of hexane, chloroform (CHCl(3)), ethyl acetate (EtOAc), and MeOH-H(2)O of Sargassum angustifolium, Chondria dasyphylla, and Ulva flexuosa, collected from coastlines of the Persian Gulf in south of Iran, were studied against colon carcinoma (HT-29), colorectal adenocarcinoma (Caco-2), breast ductal carcinoma (T47D), and Swiss mouse embryo fibroblast (NIH 3T3) cell lines by MTT assay. STATISTICAL ANALYSIS USED: IC(50) (median growth inhibitory concentration) values were calculated by Sigmaplot (10) software. RESULTS: Hexane fraction of Chondria dasyphylla (IC(50) 82.26 +/- 4.09 mug/ml) and MeOH-H(2)O fraction of Ulva flexuosa (IC(50) 116.92 +/- 8.58 mug/ml) showed cytotoxic activity against proliferation of T47D cells. Hexane fraction of Sargassum angustifolium was also observed for cytotoxicity against T47D and HT-29 cell lines (IC(50) 166.42 +/- 26.7 and 190.24 +/- 52.8 mug/ml), respectively. An investigation of a component from the hexane fraction of Sargassum angustifolium yielded a steroidal metabolite, Fucosterol, with cytotoxicity in T47D and HT29 (IC(50) 27.94 +/- 9.3 and 70.41 +/- 7.5 mug/ml). CONCLUSIONS: These results indicated that Fucosterol, the most abundant phytosterol in brown algae, is responsible for cytotoxic effect of this extract against breast and colon carcinoma cell lines.
Protective effect of fucosterol isolated from the edible brown algae, Ecklonia stolonifera and Eisenia bicyclis, on tert-butyl hydroperoxide- and tacrine-induced HepG2 cell injury.[Pubmed:25773602]
J Pharm Pharmacol. 2015 Aug;67(8):1170-8.
OBJECTIVES: Fucosterol is the primary sterol found in brown algae. Recently, considerable interest has been generated regarding Fucosterol due to its potential antioxidant, anti-inflammatory and antidiabetic effects. The aim of this study was to investigate the protective effects of Fucosterol on tert-butyl hydroperoxide (t-BHP)- and tacrine-induced oxidative stress in HepG2 cells. METHODS: Fucosterol by itself exhibited no cytotoxicity at concentrations below 100 mum by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. The increased intracellular reactive oxygen species (ROS) and decreased glutathione levels observed in t-BHP- and tacrine-treated HepG2 cells were ameliorated by Fucosterol pretreatment, indicating that the protective effects of Fucosterol are mediated by the induction of cellular defence mechanisms against oxidative stress. Moreover, elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in tacrine-treated mice were significantly reduced after oral administration of Fucosterol. KEY FINDINGS: The hepatoprotective effects of Fucosterol may occur via an increase in the hepatic level of glutathione and a decrease in ROS production, thereby preventing hepatic damage and the resultant increases in ALT and AST activity. CONCLUSION: These results suggest that Fucosterol may be an effective hepatoprotective agent that could be useful for preventive therapies against oxidative stress-related hepatotoxicity.
Fucosterol is a selective liver X receptor modulator that regulates the expression of key genes in cholesterol homeostasis in macrophages, hepatocytes, and intestinal cells.[Pubmed:23116181]
J Agric Food Chem. 2012 Nov 21;60(46):11567-75.
Fucosterol, a sterol that is abundant in marine algae, has hypocholesterolemic activity, but the mechanism underlying its effect is not clearly understood. Because data suggest that Fucosterol can increase plasma high-density lipoprotein concentrations, we investigated whether it could activate liver X receptors (LXRs), critical transcription factors in reverse cholesterol transport. Fucosterol dose-dependently stimulated the transcriptional activity of both LXR-alpha and -beta in a reporter gene assay, responses that were attenuated by the LXR antagonist As(2)O(3). Fucosterol also activated co-activator recruitment in cell-free time-resolved fluorescence resonance energy transfer analysis. In THP-1-derived macrophages, it induced the transcriptional activation of ABCA1, ABCG1, and ApoE, key genes in reverse cholesterol transport, and thereby significantly increased the efflux of cholesterol. Fucosterol also regulated intestinal NPC1L1 and ABCA1 in Caco-2 cells. Notably, Fucosterol did not induce cellular triglyceride accumulation in HepG2 cells, primarily because of its upregulation of Insig-2a, which delays nuclear translocation of SREBP-1c, a key hepatic lipogenic transcription factor. These results suggest that Fucosterol is a dual-LXR agonist that regulates the expression of key genes in cholesterol homeostasis in multiple cell lines without inducing hepatic triglyceride accumulation.
Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3T3-L1 adipocytes.[Pubmed:24014306]
Arch Pharm Res. 2014 Jun;37(6):713-20.
Fucosterol is a sterol metabolite of brown algae and regulates genes involved with cholesterol homeostasis. As a part of our continuous search for anti-obesity agents from natural marine sources, the anti-adipogenic activities of Ecklonia stolonifera and its sterol, Fucosterol, were evaluated for the inhibition of adipocyte differentiation and lipid formation. Oil Red O staining was used to evaluate triglyceride contents in 3T3-L1 pre-adipocytes primed by differentiation medium (DM) I and DM II. The methanolic extract of E. stolonifera showed strong anti-adipogenic activity, and was thus fractionated with several solvents. Among the tested fractions, the dichloromethane (CH2Cl2) fraction was found to be the most active fraction, with significant inhibition (40.5 %) of intracellular lipid accumulation at a non-toxic concentration, followed by the ethyl acetate fraction (30.2 %) at the same concentration, while the n-butanol and water fractions did not show inhibitory activity within the tested concentrations. The strong anti-adipogenic CH2Cl2-soluble fraction was further purified by a repeated chromatography to yield Fucosterol. Fucosterol reduced lipid contents in a concentration-dependent manner without showing any cytotoxicity. Fucosterol treatment also yielded a decrease in the expression of the adipocyte marker proteins peroxisome proliferator-activated receptor gamma (PPARgamma) and CCAAT/enhancer-binding protein alpha (C/EBPalpha) in a concentration-dependent manner. Taken together, these results suggest that Fucosterol inhibits expression of PPARgamma and C/EBPalpha, resulting in a decrease of lipid accumulation in 3T3-L1 pre-adipocytes, indicating that the potential use of E. stolonifera and its bioactive Fucosterol as an anti-obesity agent.
Anti-diabetic activities of fucosterol from Pelvetia siliquosa.[Pubmed:15595413]
Arch Pharm Res. 2004 Nov;27(11):1120-2.
Fucosterol isolated from Pelvetia siliquosa was tested for its anti-diabetic activity in vivo. Fucosterol, when administered orally at 30 mg/kg in streptozotocin-induced diabetic rats, was caused a significant decrease in serum glucose concentrations, and exhibited an inhibition of sorbitol accumulations in the lenses. Fucosterol, when administered orally at 300 mg/kg in epinephrine-induced diabetic rats, was also caused an inhibition of blood glucose level and glycogen degradation. These results demonstrated that Fucosterol is a main anti-diabetic principle from the marine algae P. siliquosa.
Anti-oxidant activities of fucosterol from the marine algae Pelvetia siliquosa.[Pubmed:14560919]
Arch Pharm Res. 2003 Sep;26(9):719-22.
The anti-oxidant activities of Fucosterol isolated from the marine algae Pelvetia siliquosa were investigated. Fucosterol exhibited a significant decrease in serum transaminase activities elevated by hepatic damage induced by CCl4-intoxication in rats. Fucosterol inhibited the sGOT and sGPT activities by 25.57 and 63.16%, respectively. Fucosterol showed the increase in the anti-oxidant enzymes such as hepatic cytosolic superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-px) activities by 33.89, 21.56 and 39.24%, respectively, in CCl4-intoxicated rats. These results suggest that Fucosterol possess not only the anti-oxidant, but also the hepatoprotective activities in rats.